U.S. flag

An official website of the United States government

Results: 1 to 20 of 202

Make selection to find tests for any of the checked conditions.[x]
ConditionsSynonyms
Pfeiffer syndrome
  • ACS V
  • Acrocephalosyndactyly, type 5
  • FGFR1-Related Craniosynostosis
  • Pfeiffer type acrocephalosyndactyly
Lynch syndrome 5
  • Colorectal cancer, hereditary nonpolyposis, type 5
  • Hereditary non-polyposis colorectal cancer, type 5
Fasting plasma glucose level quantitative trait locus 5
Microcephaly 5, primary, autosomal recessive
Bardet-Biedl syndrome 5
3-methylcrotonyl-CoA carboxylase 2 deficiency
  • 3 alpha methylcrotonyl-CoA carboxylase 2 deficiency
  • 3 alpha methylcrotonylglycinuria 2
  • MCC 2 deficiency
  • MCCC2-Related 3-Methylcrotonyl-CoA Carboxylase Deficiency
  • METHYLCROTONYLGLYCINURIA, TYPE II
  • Methylcrotonylglycinuria type 2
Hypercholesterolemia, familial, 1
  • Fredrickson type IIa hyperlipoproteinemia
  • HYPER-LOW-DENSITY-LIPOPROTEINEMIA
  • HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFIER OF
  • HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL
  • Hyper-beta-lipoproteinemia
  • Hyperlipoproteinemia Type II
  • Hyperlipoproteinemia Type IIa
  • Hyperlipoproteinemia type 2
  • LDL RECEPTOR DISORDER
  • LDLR-Related Familial Hypercholesterolemia, Autosomal Dominant
Osteogenesis imperfecta type 5
  • OI type 5
  • OSTEOGENESIS IMPERFECTA, TYPE V
  • Type V OI
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
  • Cox deficiency, French Canadian type
  • Cox deficiency, Saguenay Lac saint Jean type
  • Cytochrome c oxidase deficiency, French Canadian type
  • Leigh syndrome, French Canadian type
  • Leigh syndrome, Saguenay Lac saint Jean type
  • MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
  • Encephalomyopathy
  • MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA, AUTOSOMAL RECESSIVE, SUCLA2-RELATED
  • Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)
  • Mitochondrial encephalomyopathy aminoacidopathy
Atelosteogenesis type II
  • Atelosteogenesis type 2
  • NEONATAL OSSEOUS DYSPLASIA I
  • Neonatal osseous dysplasia 1
Thyroid cancer, nonmedullary, 2
  • THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO
  • THYROID CARCINOMA, FOLLICULAR
  • Thyroid carcinoma, follicular, somatic
Factor 5 and Factor VIII, combined deficiency of, 2
  • Factor v and factor viii, combined deficiency of, 2
Cerebral cavernous malformation 2
  • Cerebral cavernous malformations 2
  • Familial Cerebral Cavernous Malformation 2
Polyglandular autoimmune syndrome, type 1
  • APS 1
  • APS I
  • AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA
  • Autoimmune Polyendocrinopathy Syndrome Type 1
  • Autoimmune polyendocrine syndrome type 1
  • Autoimmune polyendocrinopathy syndrome, type I
  • Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
  • Hypoadrenocorticism with hypoparathyroidism and superficial moniliasis
  • PGA 1
  • PGA I
  • Whitaker syndrome
Neuroblastoma, susceptibility to, 2
  • Neuroblastoma 2
Interstitial lung disease 2
  • Familial Pulmonary Fibrosis
  • Familial idiopathic pulmonary fibrosis
  • Fibrocystic pulmonary dysplasia
  • Fibrosing alveolitis, cryptogenic
Sandhoff disease
  • Beta-hexosaminidase-beta-subunit deficiency
  • GM2 gangliosidosis, type 2
  • GM2-GANGLIOSIDOSIS, TYPE II
  • HEXOSAMINIDASES A AND B DEFICIENCY
  • Hexosaminidase A and B deficiency Disease
  • Sandhoff-Jatzkewitz-Pilz disease
  • Total hexosaminidase deficiency
Nonpapillary renal cell carcinoma
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
  • ARTHROGRYPOSIS, DISTAL, TYPE 5
  • ARTHROGRYPOSIS, DISTAL, TYPE IIB
  • Arthrogryposis Multiple Congenita, Ophthalmoplegia, Ptosis
  • Arthrogryposis with oculomotor limitation and electroretinal abnormalities
  • Oculomelic amyoplasia

Results: 1 to 20 of 202

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.